Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s but was never marketed.[1][2] It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.[2][3]
This article about an amine is a stub. You can help Wikipedia by expanding it.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.